RECRUITING

Role of Phosphatidylethanol in Predicting Perioperative Outcomes of Admitted Patients at UHCMC

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study aims to see if there's a link between a substance called phosphatidylethanol (PEth) and how patients who have surgery at University Hospitals do after surgery. PEth levels reflect the amount of alcohol use by someone over the past few weeks. This study is checking PEth levels on all patients who are planned to stay in the hospital for three or more days after surgery regardless if they drink alcohol. Specifically, it will look at if PEth levels are connected to problems that might come up during and after surgery, like confusion, lung or heart issues, needing blood transfusions, infections, unexpected intensive care unit (ICU) stays, and longer hospital stays. While there are reports of moderate alcohol consumption being good for the heart, there are other data that alcohol consumption can be harmful. Since there's not much information on how drinking alcohol affects health outcomes during and after surgery, especially for patients who are planned to be admitted to the hospital ward or ICU after surgery, this study will hopefully see if PEth levels before surgery can predict how patients do after the surgery. The inclusion criteria to only include patients who consume alcoholic beverages was an IRB approved modification after already recruiting 1/3 of patients.

Official Title

Role of Phosphatidylethanol in Predicting Perioperative Outcomes of Admitted Patients at UHCMC

Quick Facts

Study Start:2025-05-05
Study Completion:2025-12-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06864819

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years to 79 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 1. Age range: 21-79
  2. * 2. Patients undergoing elective surgery at UHCMC with planned ICU admission
  3. * 3. Patients undergoing elective surgery at UHCMC with expected in-hospital admission for three or more days
  4. * 4. Only patients who consume alcoholic beverages on a regular basis.
  1. * 1. Patients undergoing same day outpatient surgeries or expected to be admitted less than three days post-operatively
  2. * 2. Subjects who have received a blood transfusion within the past month before surgery
  3. * 3. Pregnant subjects

Contacts and Locations

Study Contact

Ayse Ulucay, MD
CONTACT
216-844-3771
ayse.ulucay@uhhospitals.org

Principal Investigator

Salim Hayek, MD, PhD
PRINCIPAL_INVESTIGATOR
University Hospitals

Study Locations (Sites)

University Hospital
Cleveland, Ohio, 44106
United States

Collaborators and Investigators

Sponsor: University Hospitals Cleveland Medical Center

  • Salim Hayek, MD, PhD, PRINCIPAL_INVESTIGATOR, University Hospitals

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-05-05
Study Completion Date2025-12-01

Study Record Updates

Study Start Date2025-05-05
Study Completion Date2025-12-01

Terms related to this study

Keywords Provided by Researchers

  • alcohol consumption
  • surgical outcomes

Additional Relevant MeSH Terms

  • Postoperative Complications
  • Alcohol Use Disorder